Patents Assigned to Qiagen Sciences, Inc.
  • Publication number: 20130210021
    Abstract: Disclosed is an isolated strain of a previously unknown Staphylococcus, Staphylococcus pseudolugdunensis. Also disclosed are the sequences of the S. pseudolugdunensis tuf gene and 16s rRNA and methods for distinguishing S. pseudolugdunensis from other staphylococcal species.
    Type: Application
    Filed: April 12, 2013
    Publication date: August 15, 2013
    Applicants: Qiagen Sciences, Inc., Vanderbilt University
    Inventors: Vanderbilt University, Qiagen Sciences, Inc.
  • Patent number: 8367320
    Abstract: The invention pertains to a method for performing an expression modulating analysis or assay, wherein an apoptosis inducing expression modulating compound targeting a repetitive element present in the untranslated region, in particular the 3? UTRs of protein coding gene transcripts is introduced into cells to induce apoptosis in the cells as a positive control. Also provided are suitable kits and compositions.
    Type: Grant
    Filed: December 29, 2008
    Date of Patent: February 5, 2013
    Assignee: Qiagen Sciences, Inc.
    Inventor: Eric Lader
  • Publication number: 20110070659
    Abstract: The present invention relates to sample presentation devices useful in performing analytical measurements. These devices have been configured to enable various aspects of liquid handling such as: retention, storage, transport, concentration, positioning, and transfer. Additionally, these devices can enhance the detection and characterization of analytes. The sample presentation devices of the present invention are comprised of one or more substrates having a plurality of zones of differing wettability. Methods of analyzing samples using the sample presentation device of the invention, as well as methods of making the sample presentation devices are disclosed.
    Type: Application
    Filed: May 24, 2010
    Publication date: March 24, 2011
    Applicant: Qiagen Sciences, Inc.
    Inventors: Christopher M. Belisle, John A. Walker, II, Sarah M. Ngola, Douglas P. Greiner, Mark J. Levy, Xiaoxia Zhao, Irene Y. Chen, Mark L. Stolowitz, Donald P. Paquin
  • Publication number: 20100285484
    Abstract: The invention pertains to a method for performing an expression modulating analysis or assay, wherein an apoptosis inducing expression modulating compound targeting a repetitive element present in the untranslated region, in particular the 3? UTRs of protein coding gene transcripts is introduced into cells to induce apoptosis in the cells as a positive control. Also provided are suitable kits and compositions.
    Type: Application
    Filed: December 29, 2008
    Publication date: November 11, 2010
    Applicant: QIAGEN SCIENCES, INC.
    Inventor: Eric Lader